Biomarkers for differentiation of Parkinson*s disease subtypes.
- Conditions
- Parkinson's10028037
- Registration Number
- NL-OMON39292
- Lead Sponsor
- eids Universitair Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- Not specified
- Target Recruitment
- 210
For all participants a minimum age of 18 years is required.
All PD patients must fulfill the United Kingdom Parkinson*s Disease Society Brain Bank criteria for idiopathic PD. Patients with Lewy body dementie (DLB) must fulfill the McKeith DLB criteria and all patients must be diagnosed with PD or DLB by a movement disorder specialist.
Only patients who are mental competent are included.
Participants with a contraindication for MRI are excluded.
Patients who underwent stereotactic surgery were excluded.
Controls with a disease of the central nervous system are excluded.
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The main study parameters of this study will include magnetic resonance imaging<br /><br>(MRI) parameters, and clinical measures. Clinical data include important<br /><br>demographic and disease-related characteristics as well as measures for disease<br /><br>severity, and the important motor (motor functioning and motor complications),<br /><br>and non-motor domains (cognition, depression, psychotic symptoms, sleep<br /><br>problems, and autonomic dysfunction). The combination of clinical scores will<br /><br>allocate PD patients in one of the four subtypes. MRI will be carried out on a<br /><br>3T scanner and will include volumetric, diffusion, and functional MRI<br /><br>parameters. </p><br>
- Secondary Outcome Measures
Name Time Method <p>Not applicable.</p><br>